Extending the value

CRO announces $7.8M extension agreement for OmniComm’s TrialOne

DDNews Staff
FORT LAUDERDALE, Fla.—A major full-service, global contract research organization (CRO) has expanded its existing partnership with OmniComm Systems Inc., a leading global provider of clinical data management technology. Under the terms of a new $7.8-million multiyear agreement, the CRO will utilize OmniComm’s TrialOne system to ensure regulatory compliance and bring greater operational efficiency, speed and quality to the clinical research process within its clinics.
The CRO in question will use TrialOne to implement a number of automated clinical trial processes across multiple clinics, including the recruitment and screening of subject participants, study design and the collection, analysis and reporting of data.
“We’re excited to continue building our partnership with this leading CRO,” said Dr. Kuno van der Post, chief commercial officer at OmniComm. “We are very proud to have earned their trust for increased business and commitment. It is a pleasure to work with a company that shares our passion for problem solving for clients and seeks robust, scalable and innovative solutions to help meet expectations.”
TrialOne is a browser-based bedside data collection technology specifically designed to automate the workflows and processes within early-phase research clinics.

DDNews Staff

Published In:

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

March 2023 Magazine Front Cover

Latest Issue  

• Volume 19 • Issue 3 • March 2023

March 2023

March 2023 Issue